DNLI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,273,411.08

Denali Therapeutics Insider Trading History Chart

Denali Therapeutics Share Price & Price History

^$21.45

▼ -0.04 (-0.19%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Amazon coin set to soar 25X – starting December 16th?

From True Market Insiders | Ad

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

>3-Cent Amazon Coin<

Denali Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2024	Alexander O Schuth	Insider	Sell	15,558	$29.91	$465,339.78	178,066
11/7/2024	Vicki L. Sato	Director	Sell	1,020	$30.00	$30,600.00	111,056
10/18/2024	Ryan J Watts	CEO	Sell	40,000	$27.69	$1,107,600.00	235,807
9/30/2024	Steve E Krognes	Director	Sell	30,000	$29.03	$870,900.00	29,096
7/1/2024	Steve E Krognes	Director	Sell	30,000	$22.12	$663,600.00	34,404
6/13/2024	Steve E Krognes	Director	Sell	688	$21.79	$14,991.52	52,620
6/6/2024	Jennifer E. Cook	Director	Sell	1,458	$21.73	$31,682.34	20,038
4/15/2024	Vicki L. Sato	Director	Sell	1,666	$18.29	$30,471.14	118,043
4/1/2024	Steve E Krognes	Director	Sell	92,500	$20.50	$1,896,250.00	47,341
2/15/2024	Vicki L. Sato	Director	Sell	1,666	$18.37	$30,604.42	121,375
2/13/2024	Carole Ho	Insider	Sell	2,784	$17.29	$48,135.36	145,010
2/13/2024	Ryan J Watts	CEO	Sell	9,589	$17.29	$165,793.81	238,067
2/13/2024	Steve E Krognes	Director	Sell	2,750	$17.29	$47,547.50	139,841
1/16/2024	Vicki L. Sato	Director	Sell	1,666	$18.42	$30,687.72	123,041
1/10/2024	Carole Ho	Insider	Sell	4,668	$19.02	$88,785.36	147,794
1/9/2024	Ryan J Watts	CEO	Sell	7,818	$19.78	$154,640.04	2,268,363
1/5/2024	Carole Ho	Insider	Sell	9,972	$19.43	$193,755.96	198,777
1/5/2024	Ryan J Watts	CEO	Sell	17,483	$19.43	$339,694.69	2,276,181
1/5/2024	Steve E Krognes	Director	Sell	3,208	$19.43	$62,331.44	142,591
12/15/2023	Vicki L. Sato	Director	Sell	1,666	$23.39	$38,967.74	124,707
11/15/2023	Vicki L. Sato	Director	Sell	1,666	$19.13	$31,870.58	126,373
10/16/2023	Vicki L. Sato	Director	Sell	1,666	$20.66	$34,419.56	128,039
9/15/2023	Vicki L. Sato	Director	Sell	1,666	$23.62	$39,350.92	129,705
8/23/2023	Carole Ho	Insider	Sell	2,522	$23.22	$58,560.84	182,809
8/21/2023	Carole Ho	Insider	Sell	2,478	$22.60	$56,002.80	185,331
8/21/2023	Carole Ho	Insider	Sell	2,478	$22.60	$56,002.80	185,331
8/21/2023	Ryan J Watts	CEO	Sell	2,309	$22.59	$52,160.31	2,242,604
8/21/2023	Ryan J Watts	CEO	Sell	2,309	$22.59	$52,160.31	2,242,604
8/21/2023	Steve E Krognes	Director	Sell	1,419	$22.60	$32,069.40	145,799
8/21/2023	Steve E Krognes	Director	Sell	1,419	$22.60	$32,069.40	145,799
8/15/2023	Vicki L. Sato	Director	Sell	1,666	$24.30	$40,483.80	131,371
8/14/2023	Carole Ho	Insider	Sell	2,768	$23.79	$65,850.72	182,809
8/10/2023	Carole Ho	Insider	Sell	2,857	$24.15	$68,996.55	185,577
8/10/2023	Ryan J Watts	CEO	Sell	2,526	$25.03	$63,225.78	2,239,913
7/17/2023	Alexander O Schuth	Insider	Sell	10,000	$29.60	$296,000.00	528,691
7/17/2023	Vicki L. Sato	Director	Sell	1,666	$29.60	$49,313.60	133,037
6/28/2023	Vicki L. Sato	Director	Sell	1,666	$29.84	$49,713.44	134,703
5/15/2023	Alexander O Schuth	Insider	Sell	10,000	$28.60	$286,000.00	528,691
4/20/2023	Ryan J Watts	CEO	Sell	200	$25.00	$5,000.00	2,239,913
4/12/2023	Alexander O Schuth	Insider	Sell	5,102	$25.04	$127,754.08	528,691
2/13/2023	Carole Ho	Insider	Sell	2,548	$30.10	$76,694.80	184,285
2/13/2023	Ryan J Watts	CEO	Sell	33,815	$30.08	$1,017,155.20	2,239,913
2/13/2023	Steve E Krognes	Director	Sell	2,119	$30.10	$63,781.90	143,002
2/10/2023	Carole Ho	Insider	Sell	818	$29.80	$24,376.40	179,365
2/10/2023	Ryan J Watts	CEO	Sell	25,000	$29.10	$727,500.00	2,229,031
2/8/2023	Carole Ho	Insider	Sell	1,521	$30.88	$46,968.48	180,183
2/8/2023	Steve E Krognes	Director	Sell	1,377	$30.88	$42,521.76	145,121
1/17/2023	Alexander O Schuth	Insider	Sell	10,000	$29.53	$295,300.00	497,173
1/9/2023	Carole Ho	Insider	Sell	1,459	$28.48	$41,552.32	177,454
1/6/2023	Carole Ho	Insider	Sell	1,451	$28.67	$41,600.17	178,913
1/5/2023	Steve E Krognes	Director	Sell	2,970	$28.44	$84,466.80	146,498
1/4/2023	Carole Ho	Insider	Sell	2,913	$28.69	$83,573.97	175,500
1/4/2023	Ryan J Watts	CEO	Sell	5,029	$28.73	$144,483.17	2,213,464
11/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.48	$609,600.00	1,870,356
11/1/2022	Marc Tessier-Lavigne	Director	Sell	8,748	$30.20	$264,189.60	1,901,608
9/28/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$30.82	$616,400.00	1,910,356
8/23/2022	Carole Ho	Insider	Sell	2,424	$31.98	$77,519.52	170,663
8/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$31.61	$632,200.00	1,930,356
8/19/2022	Alexander O Schuth	Insider	Sell	2,576	$33.22	$85,574.72	467,471
8/19/2022	Ryan J Watts	CEO	Sell	2,404	$33.22	$79,860.88	2,202,993
8/19/2022	Steve E Krognes	Director	Sell	2,253	$33.22	$74,844.66	149,468
7/25/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$35.61	$712,200.00	1,950,356
3/23/2022	Marc Tessier-Lavigne	Director	Sell	20,000	$33.83	$676,600.00
2/11/2022	Alexander O Schuth	COO	Sell	2,803	$34.68	$97,208.04
2/11/2022	Carole Ho	Insider	Sell	2,918	$34.71	$101,283.78
2/11/2022	Ryan J Watts	CEO	Sell	9,491	$34.72	$329,527.52
2/11/2022	Steve E Krognes	CFO	Sell	2,560	$34.69	$88,806.40
2/9/2022	Alexander O Schuth	COO	Sell	1,423	$37.10	$52,793.30
2/9/2022	Ryan J Watts	CEO	Sell	2,719	$37.55	$102,098.45
2/9/2022	Steve E Krognes	CFO	Sell	1,296	$37.09	$48,068.64
1/5/2022	Alexander O Schuth	COO	Sell	2,846	$44.77	$127,415.42
1/5/2022	Carole Ho	Insider	Sell	2,845	$44.78	$127,399.10
1/5/2022	Ryan J Watts	CEO	Sell	5,007	$44.78	$224,213.46
1/5/2022	Steve E Krognes	CFO	Sell	2,225	$44.75	$99,568.75
12/30/2021	Marc Tessier-Lavigne	Director	Sell	20,047	$45.36	$909,331.92
12/28/2021	Marc Tessier-Lavigne	Director	Sell	10,980	$44.37	$487,182.60

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

SEC Filings (Institutional Ownership Changes) for Denali Therapeutics (NASDAQ:DNLI)

92.92% of Denali Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Denali Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	1,238,476	$36.08M	0.0%	+13.8%	0.861%
11/27/2024	Franklin Resources Inc.	80,041	$2.15M	0.0%	+3.8%	0.056%
11/16/2024	Geode Capital Management LLC	2,955,477	$86.11M	0.0%	-0.9%	2.054%
11/15/2024	Barclays PLC	255,883	$7.45M	0.0%	+101.4%	0.178%
11/15/2024	Nomura Asset Management Co. Ltd.	65,033	$1.89M	0.0%	N/A	0.045%
11/15/2024	Y Intercept Hong Kong Ltd	13,823	$0.40M	0.0%	-64.7%	0.010%
11/15/2024	Pier Capital LLC	168,082	$4.90M	0.7%	+1.6%	0.117%
11/15/2024	Wellington Management Group LLP	10,727,450	$312.49M	0.1%	+9.2%	7.454%
11/15/2024	Temasek Holdings Private Ltd	5,355,832	$156.02M	0.6%	-6.1%	3.721%
11/15/2024	State Street Corp	4,252,011	$123.86M	0.0%	-4.1%	2.954%
11/15/2024	Stifel Financial Corp	9,839	$0.29M	0.0%	-23.4%	0.007%
11/15/2024	Point72 Asset Management L.P.	333,530	$9.72M	0.0%	-68.3%	0.232%
11/15/2024	Polar Asset Management Partners Inc.	41,100	$1.20M	0.0%	+70.5%	0.029%
11/15/2024	HighTower Advisors LLC	37,327	$1.09M	0.0%	-1.5%	0.026%
11/15/2024	Holocene Advisors LP	97,447	$2.84M	0.0%	+65.0%	0.068%
11/15/2024	Cinctive Capital Management LP	149,094	$4.34M	0.2%	+32.7%	0.104%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	3,764	$0.11M	0.0%	-54.8%	0.003%
11/15/2024	Erste Asset Management GmbH	26,900	$0.79M	0.0%	N/A	0.019%
11/14/2024	Bellevue Group AG	15,700	$0.46M	0.0%	N/A	0.011%
11/14/2024	Wasatch Advisors LP	238,881	$6.96M	0.0%	-40.6%	0.166%
11/14/2024	Fred Alger Management LLC	121,316	$3.53M	0.0%	+349.1%	0.084%
11/14/2024	Northwest & Ethical Investments L.P.	68,643	$2M	0.1%	-9.5%	0.048%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	3,749,486	$109.22M	0.0%	+63.2%	2.605%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	29,719	$0.87M	0.0%	+12.6%	0.021%
11/13/2024	BNP Paribas Financial Markets	27,625	$0.81M	0.0%	+230.2%	0.019%
11/13/2024	FMR LLC	7,831,378	$228.13M	0.0%	+3,234.3%	5.441%
11/13/2024	The Manufacturers Life Insurance Company	206,819	$6.03M	0.0%	+20.0%	0.144%
11/13/2024	Fisher Asset Management LLC	547,331	$15.94M	0.0%	+14.5%	0.380%
11/12/2024	Pitcairn Co.	11,259	$0.33M	0.0%	N/A	0.008%
11/12/2024	Algert Global LLC	48,630	$1.42M	0.0%	+82.4%	0.034%
11/12/2024	Charles Schwab Investment Management Inc.	1,015,810	$29.59M	0.0%	-4.1%	0.706%
11/9/2024	Intech Investment Management LLC	29,543	$0.86M	0.0%	N/A	0.021%
11/7/2024	Quest Partners LLC	2,512	$73K	0.0%	N/A	0.002%
11/7/2024	Swiss National Bank	250,700	$7.30M	0.0%	+7.7%	0.175%
11/7/2024	Thrivent Financial for Lutherans	138,862	$4.05M	0.0%	+6.4%	0.097%
11/6/2024	Pier 88 Investment Partners LLC	59,170	$1.72M	0.4%	-14.7%	0.041%
11/5/2024	Victory Capital Management Inc.	39,900	$1.16M	0.0%	+163.7%	0.028%
11/5/2024	Baillie Gifford & Co.	13,345,887	$388.77M	0.3%	-3.0%	9.322%
11/4/2024	Los Angeles Capital Management LLC	27,940	$0.81M	0.0%	-47.1%	0.020%
11/4/2024	State of New Jersey Common Pension Fund D	77,483	$2.26M	0.0%	-24.8%	0.054%
11/1/2024	Assetmark Inc.	3,808	$0.11M	0.0%	+18.0%	0.003%
11/1/2024	AIA Group Ltd	74,815	$2.18M	0.1%	+7.9%	0.052%
10/31/2024	Principal Financial Group Inc.	1,238,476	$36.08M	0.0%	+13.8%	0.868%
10/29/2024	VELA Investment Management LLC	15,635	$0.46M	0.1%	N/A	0.011%
10/28/2024	US Bancorp DE	1,168	$34K	0.0%	-27.7%	0.001%
10/25/2024	MONECO Advisors LLC	9,100	$0.27M	0.0%	+4.6%	0.006%
10/25/2024	Integrated Advisors Network LLC	9,710	$0.28M	0.0%	N/A	0.007%
10/25/2024	China Universal Asset Management Co. Ltd.	27,535	$0.80M	0.1%	+64.4%	0.019%
10/25/2024	abrdn plc	363,679	$10.59M	0.0%	-36.5%	0.255%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	5,178	$0.15M	0.0%	+21.6%	0.004%
10/19/2024	Allspring Global Investments Holdings LLC	5,676	$0.17M	0.0%	-6.9%	0.004%
10/16/2024	nVerses Capital LLC	9,900	$0.29M	0.1%	N/A	0.007%
10/11/2024	Creative Planning	60,254	$1.76M	0.0%	+40.0%	0.042%
10/8/2024	CWM LLC	2,153	$63K	0.0%	+43.6%	0.002%
10/3/2024	SG Americas Securities LLC	4,808	$0.14M	0.0%	-65.2%	0.003%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	8,335	$0.19M	0.0%	N/A	0.006%
8/27/2024	Dana Investment Advisors Inc.	34,269	$0.80M	0.0%	+19.2%	0.024%
8/16/2024	Quarry LP	6,500	$0.15M	0.0%	-7.1%	0.005%
8/16/2024	Creative Planning	43,033	$1M	0.0%	+8.7%	0.030%
8/16/2024	Algert Global LLC	26,655	$0.62M	0.0%	-67.5%	0.019%
8/15/2024	Susquehanna Fundamental Investments LLC	222,917	$5.18M	0.1%	+5.6%	0.156%
8/15/2024	The Manufacturers Life Insurance Company	172,281	$4M	0.0%	+15.5%	0.121%
8/15/2024	Millennium Management LLC	619,929	$14.40M	0.0%	+58.7%	0.435%
8/15/2024	AXA S.A.	344,785	$8.01M	0.0%	-4.4%	0.242%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	8,335	$0.19M	0.0%	N/A	0.006%
8/14/2024	Squarepoint Ops LLC	123,680	$2.87M	0.0%	+90.6%	0.087%
8/14/2024	Fred Alger Management LLC	27,014	$0.63M	0.0%	N/A	0.019%
8/14/2024	Point72 Asset Management L.P.	1,053,150	$24.45M	0.1%	N/A	0.736%
8/14/2024	Marshall Wace LLP	2,418,833	$56.17M	0.1%	+12.7%	1.696%
8/14/2024	Integral Health Asset Management LLC	325,000	$7.55M	0.7%	N/A	0.228%
8/14/2024	ProShare Advisors LLC	24,798	$0.58M	0.0%	-20.5%	0.017%
8/14/2024	Profund Advisors LLC	29,373	$0.68M	0.0%	-57.1%	0.021%
8/13/2024	Thrivent Financial for Lutherans	130,504	$3.03M	0.0%	+101.5%	0.092%
8/13/2024	Sei Investments Co.	22,670	$0.53M	0.0%	+87.8%	0.016%
8/12/2024	Hsbc Holdings PLC	29,642	$0.67M	0.0%	+83.1%	0.021%
8/12/2024	Vanguard Personalized Indexing Management LLC	10,790	$0.25M	0.0%	N/A	0.008%
8/12/2024	E Fund Management Co. Ltd.	9,200	$0.21M	0.0%	-55.2%	0.006%
8/9/2024	Dimensional Fund Advisors LP	1,417,472	$32.91M	0.0%	+6.3%	0.994%
8/8/2024	DekaBank Deutsche Girozentrale	59,800	$1.37M	0.0%	-6.9%	0.042%
8/8/2024	American Century Companies Inc.	522,594	$12.14M	0.0%	+13.7%	0.366%
8/8/2024	State of New Jersey Common Pension Fund D	103,096	$2.39M	0.0%	-37.5%	0.072%
8/7/2024	Pier Capital LLC	165,486	$3.84M	0.6%	-4.0%	0.116%
8/7/2024	ClariVest Asset Management LLC	22,964	$0.53M	0.1%	-51.9%	0.016%
8/6/2024	Pier 88 Investment Partners LLC	69,370	$1.61M	0.4%	+73.6%	0.049%
8/6/2024	Letko Brosseau & Associates Inc.	11,350	$0.26M	0.0%	N/A	0.008%
8/6/2024	Los Angeles Capital Management LLC	52,863	$1.23M	0.0%	-4.9%	0.037%
8/6/2024	Candriam S.C.A.	726,499	$16.87M	0.1%	+62.2%	0.509%
8/5/2024	Arizona State Retirement System	33,114	$0.77M	0.0%	+9.0%	0.023%
8/3/2024	TD Asset Management Inc	179,152	$4.16M	0.0%	+4.5%	0.126%
8/1/2024	Rhumbline Advisers	194,859	$4.53M	0.0%	+13.3%	0.137%
7/29/2024	Principal Financial Group Inc.	1,088,537	$25.28M	0.0%	-3.0%	0.763%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	26,403	$0.61M	0.0%	+5.5%	0.019%
7/26/2024	Bank of New York Mellon Corp	1,540,271	$35.77M	0.0%	-13.4%	1.080%
7/25/2024	Baillie Gifford & Co.	13,763,596	$319.59M	0.2%	-2.0%	9.651%
7/20/2024	China Universal Asset Management Co. Ltd.	16,753	$0.39M	0.1%	-37.3%	0.012%
7/19/2024	MONECO Advisors LLC	8,700	$0.20M	0.0%	N/A	0.006%
7/17/2024	Hamilton Lane Advisors LLC	25,657	$0.60M	0.5%	N/A	0.018%
7/12/2024	SG Americas Securities LLC	13,808	$0.32M	0.0%	+93.4%	0.010%
7/11/2024	Clarius Group LLC	409,995	$9.52M	0.7%	+4.5%	0.287%
7/2/2024	GAMMA Investing LLC	2,057	$48K	0.0%	+879.5%	0.001%

Data available starting January 2016

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs include DNL310 ETV, an IDS enzyme replacement therapy program for MPS II; TAK-594/DNL593 which is in Phase 1/II for frontotemporal dementia-granulin; DNL126 program for MPS IIIA; and DNL622 for MPS I, as well as other preclinical programs that target amyloid beta and HER2. Its brain-penetrant small molecule programs comprise BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; SAR443820/DNL788 RIPK1 inhibitor program for CNS disease; DNL343 eIF2B Activator program for amyotrophic lateral sclerosis; and SAR443122/DNL758 RIPK1 inhibitor program for peripheral inflammatory diseases. It also provides early stage program include TAK-594/DNL593 program for FTD-GRN; DNL126 program for MPS IIIA, a Sanfilippo Syndrome A; DNL622 for MPS I which is Hurler syndrome; Antibody Transport Vehicle Amyloid beta program; Oligonucleotide Transport Vehicle platform, a novel class of biotherapeutics to address the root cause of diseases through modulation of gene expression; and other TV-enabled discovery programs. The company has collaboration agreements with Biogen MA Inc. and Biogen International GmbH; Genzyme Corporation; Takeda Pharmaceutical Company Limited; F-star Gamma Limited, F-star Biotechnologische Forschungs-und Entwicklungsges m.b.H, and F-star Biotechnology Limited; and Genentech, Inc. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

Today's Range

Now: $21.45

$21.00

$22.21

50 Day Range

MA: $25.82

$21.43

$31.58

52 Week Range

Now: $21.45

$14.56

$33.33

Volume

2,810,606 shs

Average Volume

1,062,494 shs

Market Capitalization

$3.09 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Who are the company insiders with the largest holdings of Denali Therapeutics?: Denali Therapeutics' top insider investors include:
Ryan J Watts (CEO)
Alexander O Schuth (Insider)
Carole Ho (Insider)
Steve E Krognes (Director)
Vicki L Sato (Director)
Jennifer E Cook (Director)
Learn More about top insider investors at Denali Therapeutics.
Who are the major institutional investors of Denali Therapeutics?: Denali Therapeutics' top institutional shareholders include:
Baillie Gifford & Co. — 9.32%
Wellington Management Group LLP — 7.45%
FMR LLC — 5.44%
Temasek Holdings Private Ltd — 3.72%
State Street Corp — 2.95%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 2.61%
Learn More about top institutional investors of Denali Therapeutics stock.
Which major investors are selling Denali Therapeutics stock?: Within the previous quarter, DNLI stock was sold by these institutional investors:
Point72 Asset Management L.P.
Baillie Gifford & Co.
Temasek Holdings Private Ltd
abrdn plc
State Street Corp
Wasatch Advisors LP
Charles Schwab Investment Management Inc.
Geode Capital Management LLC
During the last year, company insiders that have sold Denali Therapeutics company stock include:
Ryan J Watts (CEO)
Alexander O Schuth (Insider)
Carole Ho (Insider)
Steve E Krognes (Director)
Vicki L Sato (Director)
Jennifer E Cook (Director)
Learn More investors selling Denali Therapeutics stock.
Which major investors are buying Denali Therapeutics stock?: Within the last quarter, DNLI stock was purchased by institutional investors including:
FMR LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Wellington Management Group LLP
Principal Financial Group Inc.
Principal Financial Group Inc.
Barclays PLC
Fred Alger Management LLC
Fisher Asset Management LLC